Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis

Area of Science:

• Neuroscience
• Neurology
• Radiology

Background:

• Grey matter damage is prevalent in multiple sclerosis (MS) and linked to clinical symptoms, particularly cognitive impairment.
• Current understanding of cognitive impairment in MS is incomplete, necessitating better characterization.
• Existing clinical and MRI studies support the association between grey matter damage and cognitive deficits.

Purpose of the Study:

• To highlight the need for standardized, sensitive neuropsychological tests for MS.
• To emphasize the necessity of integrating imaging measures beyond grey matter.
• To explore the role of white matter integrity and cortical reorganisation in MS cognitive function.

Main Methods:

• Review of clinical and MRI findings in multiple sclerosis patients.
• Analysis of imaging measures including grey matter, lesioned white matter, and normal-appearing white matter.
• Consideration of findings related to cortical reorganisation and brain plasticity.

Main Results:

• Grey matter damage is a significant factor in MS cognitive impairment.
• White matter abnormalities (lesioned and normal-appearing) suggest an underlying disconnection syndrome.
• Cortical reorganisation and cognitive reserve contribute to mitigating cognitive deficits.

Conclusions:

• Clinical and imaging biomarkers are essential for monitoring MS progression and treatment efficacy.
• Early identification of MS patients at risk for cognitive impairment is critical.
• A comprehensive approach combining neuropsychological testing and advanced imaging is needed to fully understand MS-related cognitive decline.